Introduction {#s1}
============

Formation of the neocortex in mammals is a critical developmental milestone that entails expansion of diverse progenitors and generation of a vast array of neuronal types destined to occupy a highly organized structure ([@bib10]). Human embryonic and induced pluripotent stem cells permitting experimental access to neural cells and differentiation stages that are otherwise difficult or impossible to reach in humans, are an essential means for understanding human biology in health and disease.

During development, the emergence in human and non-human primates of a larger cortex with greater complexity involves highly derived features including expanded progenitor zones and a relatively protracted time course of neurogenesis reflected in tightly controlled, proliferative and/or neurogenic potential of progenitor cells ([@bib78]; [@bib61]). Additionally, an early event in primate forebrain development is the appearance of a transient zone, the subplate (SP), below the emerging cortical plate layers ([@bib10]; [@bib76]). The SP is a highly dynamic zone of the developing cerebral cortex that expands dramatically in human and non-human primates to become the largest compartment of the fetal neocortical wall ([@bib22]). It is composed of a heterogeneous cell population that includes migrating and post-migratory neurons, and many ingrowing axons forming transient axon terminals ([@bib76]). Interestingly, it comprises some of the earliest-born cortical neurons while disturbances in the SP have been associated with neurodevelopmental disorders ([@bib34]; [@bib38]).

The molecular identity and behavior of cortical precursors and the generation of appropriate cell fates during corticogenesis is achieved through precise regulation of spatio-temporal gene expression involving conserved and divergent developmental programs ([@bib78]). miRNAs represent a powerful component of this regulatory machinery by promoting cell fate transitions in the human and non-human primate cortex ([@bib59]). Mature miRNAs are a class of short non-coding RNAs of \~22 nucleotides in length that mediate post-transcriptional regulation of gene expression through direct degradation of their target mRNA and/or suppression of translation. miRNAs bind to their mRNA-targets in a sequence complementary fashion while recognition is primarily determined through a 'seed' region in the miRNA ([@bib5]). Following evolutionary adaptations, more than 100 primate-specific and 14 human-specific miRNAs have been identified in the developing brain ([@bib36]; [@bib7]). It has been shown that certain primate miRNAs uniquely distinguish different regions within the proliferative cortical germinal zones, while their target genes are principally involved in the regulation of cell-cycle and neurogenesis as well as in human neurodevelopmental disorders ([@bib4]). Therefore species-specific features, including miRNAs, can be critical towards the elucidation of processes as intricate as human neural development, not the least because these may also relate to neuropsychiatric and behavioral pathologies bearing a neurodevelopmental origin.

To identify miRNAs with a key role in early human neural development, we investigated miRNA expression during neural induction of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs), a stage marking the entry of multipotent ectodermal cells into the neural lineage ([@bib57]) and characterized by neural progenitor cell (NPC) expansion and early neuron generation. Systematic analysis of miRNA expression profiling revealed that a primate-specific miRNA, namely miR-934 (miRBase v21, [@bib41]), displays a striking stage-specific expression during neural induction. The significance of this expression pattern was validated by comparison with data from early to mid-gestation human fetal cortical tissue. Here we present functional evidence complemented by molecular data, demonstrating that mir-934 impacts on the progenitor-to-neuroblast transition. Further, the miR-934-mediated transcriptional neurogenic program affects subsequent neuronal differentiation processes and modulates the expression of SP-enriched genes.

Results {#s2}
=======

Transcriptome profiling for coding and small non-coding RNAs during directed human neuronal differentiation in vitro {#s2-1}
--------------------------------------------------------------------------------------------------------------------

We performed a directed differentiation protocol of hESCs/iPSCs towards hESC/iPSC-derived neural progenitors (NPCs) (13 days in vitro; DIV) and hESC/iPSC-derived neurons (48 DIV) ([Figure 1a](#fig1){ref-type="fig"}). We used the hESC line HUES6 (15) and iPSC lines \[C1-1 and C1-2 clones derived from skin fibroblasts of a male healthy donor and PD1-1 and PD1-2 clones derived from skin fibroblasts of a male patient with familial Parkinson's disease (PD)\] generated and characterized as previously described ([@bib39]). For directed differentiation ([Figure 1a](#fig1){ref-type="fig"}), hESCs/iPSCs with characteristic expression of the pluripotency state transcription factor Nanog were allowed to form embryoid bodies (0--6 DIV) ([@bib12]). Neural induction towards anterior neuroectoderm was initiated in the presence of Noggin and TGFβ inhibitor, which favor the generation and expansion of Pax6+/Nestin+ cortical progenitor cells (NPCs) and the emergence of DCX+ neuroblasts/early neurons (NPC stage, 6--15 DIV; [Figure 1a](#fig1){ref-type="fig"}). Cells were then directed to differentiate further into neurons (15--48 DIV), which became prevalent in culture at 48 DIV ([Figure 1a](#fig1){ref-type="fig"}). RNA sequencing of long and small transcripts was performed at distinct stages of directed differentiation corresponding to hESCs/iPSCs, hESC/iPSC-derived NPCs (13 DIV) and hESC/iPSC-derived neurons (48 DIV). Global expression profiling of hESCs/iPSCs and their differentiated NPCs and neuronal derivatives confirmed a reset in both mRNA and miRNA expression following fibroblast reprogramming ([Figure 1b--f](#fig1){ref-type="fig"}). Distinct within-stage groupings were observed in the correlation map and the heatmap performed using the 300 most variable long RNA genes, respectively ([Figure 1b,e](#fig1){ref-type="fig"}). As shown in the heatmap in [Figure 1g](#fig1){ref-type="fig"}, the pluripotency markers NANOG and OCT4 (POU5F1) are primarily expressed in hESCs/iPSCs, while SOX2 has a more widespread profile, reflecting its association with both the pluripotency and NPC states. Expression of the neuronal precursor marker PAX6 and the proneural genes Neurogenins 1 and 2 (NEUROG1 and NEUROG2), characteristic of dorsal telenchephalon, and the early neuronal markers NCAM1 and DCX are already evident in NPC samples, while the neuronal marker MAP2 is most abundant at the more progressed neuronal differentiation stage. The up-regulated expression of PAX6 and DCX at the NPC stage was further validated by qRT-PCR ([Figure 1h](#fig1){ref-type="fig"}).

![Directed neural differentiation of hESC/iPSC and RNA/small RNA sequencing at distinct stages of differentiation.\
(**A**) Schematic representation of directed neural differentiation of hESCs/iPSCs. Embryoid body (EB) formation (5--6 DIV) is followed by dual SMAD inhibition for neural induction and NPC generation (14--15 DIV). Neuronal differentiation then proceeds until 43--48 DIV in the presence of indicated factors. hESCs are positive for the pluripotency marker Nanog. At 12 DIV, characteristic rosettes comprising NPCs double-positive for Pax6 and Nestin are evident while DCX-positive neuroblasts/early born neurons are also seen. βΙΙΙ-tubulin (TUJ-1)-positive neurons are predominantly detected at 48 DIV. Scale bar = 40 μm; (**B**) RNA expression correlation map incorporating the 300 RNA genes with highest standard deviations across all samples; groups exhibit distinct expression patterns and within-group uniformity. Darker blue colors depict stronger positive correlations between samples, as calculated by Pearson's correlation coefficient. (**C**) Heatmap depicting similarity between samples based on expression of the 50 most expressed miRNAs. Darker blue colors denote higher similarity. (**D**) Graph depicting the first two principal components (PC1, PC2) of the top 1000 miRNAs with the highest variance across all samples. All groups exhibit distinct expression patterns and within-group uniformity. Samples: Fibroblasts (green): 1, Fetal; 2. Control (C1); 3, PD-1; hESCs/iPSCs (magenta): 4, hESCs; 5, C1 iPSCs; 6, C2 iPSCs; 7, PD1 iPSCs; 8, PD2 iPSCs; iPSC-derived NPCs (purple): 9, hESC-NPCs; 10, C1 NPCs ; 11, C2 NPCs ; 12, PD1 NPCs; 13, PD2 NPCs; iPSC-derived neurons (orange): 14, hESC-neurons ; 15, C1 neurons ; 16, C2 neurons; 17, PD1 neurons; 18, PD2 neurons. (**E**) Heatmap depicting Z scores of log2-transformed expression levels of the 300 genes with highest variance across all samples. (**F**) Heatmap depicting Z scores of log2-transformed expression levels of the 250 miRNAs with highest variance across all samples. (**G**) Heatmap showing that expression of proneural and neuronal markers starts at the stage of neural induction. (**H**) RT-qPCR analysis shows up-regulation of Pax6 and DCX mRNA at NPC stage (n = 3, for Pax6 31.1[+]{.ul}10.1 at the NPC stage; p=0.006 compared to HUES6, and for DCX 5[+]{.ul}0.58 at the NPC stage; p=0.01 compared to HUES6). Bars and error bars represent mean values and the corresponding SEMs; 0.01\<\*p\<0.05; 0.001\<\*\*p\<0.01.\
Figure 1---source data 1.qRT PCR data for PAX6 and DCX relative expression.](elife-50561-fig1){#fig1}

Identification of miR-934 with species- and stage-specific expression during progenitor expansion and early neuron generation {#s2-2}
-----------------------------------------------------------------------------------------------------------------------------

Small non-coding RNA expression also characterized the stage of cell differentiation, as demonstrated by clustering of the 50 most expressed miRNAs, and the principal component analysis based on the expression of 1000 most variable miRNAs ([Figure 1c,d](#fig1){ref-type="fig"}). This result was confirmed by unsupervised machine learning (clustering of gene expression) for the 250 miRNAs with most variable expression ([Figure 1f](#fig1){ref-type="fig"}). Further examination of miRNA sequencing data verified that the miR-302--367 cluster is highly expressed in the pluripotency stage ([Figure 2a](#fig2){ref-type="fig"}; [@bib48]), whilst miR-9 and miR-125 which are implicated in neuronal differentiation characterize primarily the progressed neuronal stage (the significance for differential expression was p\<0.05 vs all other stages) ([@bib8]; [@bib18]). On the other hand, miR-124 with a similar function in neurogenesis ([@bib89]) and abundant expression in the mature mammalian nervous system exhibited a more widespread expression pattern from NPCs to neurons (p\<0.05 for neurons compared to fibroblasts and hESCs/iPSCs, and p=0.06 compared to NPCs) ([Figure 2a](#fig2){ref-type="fig"}). The mRNA and miRNA expression data derived from our analysis confirm the validity of our in vitro system to simulate distinct stages of human neurogenesis and differentiation.

![miR-934 is specifically expressed during progenitor expansion and early neuron generation.\
(**A**) Heatmap profiling the expression of selected characteristic miRNAs across directed neural differentiation of hESCs/iPSCs to NPCs and neurons, demonstrating also the high expression of miR-934 during neural induction (Fibroblasts vs NPCs; p=0.0004, iPSCs vs NPCs; p=0.0001, Neurons vs NPCs; p=3.5×10^−6^). Warmer colors signify higher expression Z scores of the log2-transformed expression values. (**B**) Heatmap profiling the expression (log2; reads per million) of 144 miRNAs with stage specificity (tau \>0.7) which are sorted based on median expression in NPCs. miR-934 is the highest expressed miRNA in NPCs and clearly segregated, exhibiting a stage-specific expression pattern. Red arrow denotes miR-934 ranking on the top, while warmer and cooler colors signify higher and lower expression values, respectively. The blue and purple arrows indicate hsa-miR-302d-5p and hsa-miR-302b-5p, respectively, which are selected in the HUES/iPSCs stage. (**C**) RT-qPCR analysis of hESCs and their NPC- and neuronal derivatives confirms the highly segregated expression of miR-934 at the neural induction stage (2.6[+]{.ul}0.2, n = 3, p=0.006). (**D**) Chromosomal location of miR-934 in human and non-human primate species (adapted from UCSC Genome Browser. (**E, F**) Graphs incorporating miRNA expression data from uniformly-analyzed small RNA-Seq libraries (detailed in [Supplementary file 4](#supp4){ref-type="supplementary-material"}) corresponding to human fetal and adult neural tissue (**E**) and cellular samples with reference to our NPCs data (**F**). miR-934 expression shows selective expression in samples associated with human cortical development in vivo and neural induction in vitro. Bars and error bars represent mean values and the corresponding SEMs; 0.001\<\*\*p\<0.01.\
Figure 2---source data 1.qRT PCR data for hsa-miR-934 relative expression.](elife-50561-fig2){#fig2}

To identify molecular mechanisms underlying early human neurogenesis, we looked for miRNAs associated with the stage of neural induction. To locate stage-specific miRNA regulators, we adopted the tissue-specificity index tau, which is a reliable method for estimation of gene expression specificity that has been shown to outperform other relevant indices ([@bib42]). Calculation of tau index across the distinct differentiation phases revealed that 144 miRNAs exhibited a highly specific expression profile (tau \>0.7) ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). For example, members of the miR-302--367 cluster, which is a known marker of pluripotency ([@bib48]) was allocated at the hESC/iPSC stage (Fig, 2b and [Supplementary file 1](#supp1){ref-type="supplementary-material"}). When these 144 miRNAs exhibiting tissue specificity (tau \>0.7) were ranked by decreasing order of median expression in NPCs, miR-934 emerged on top of the list, scoring the highest expression among other miRNAs at the NPC stage and a strikingly segregated expression as compared to all other stages (tau value 0.76) ([Figure 2b](#fig2){ref-type="fig"}; [Supplementary file 2](#supp2){ref-type="supplementary-material"}). Moreover, according to median expression differences, no other miRNA was identified to have such a clear disparity against other stages.

The high and segregated expression of miR-934 during neural induction was verified by RT-qPCR in hESC-derived NPCs. Concurrently, miR-934 expression was undetectable in hESCs and hESC-derived neurons ([Figure 2c](#fig2){ref-type="fig"}). In silico search and further analysis revealed that miR-934 is only annotated in certain primates, including humans (miRBase v21, June 2017); it has been experimentally identified in *Homo sapiens* and *Macaca mulatta*, while it has been predicted in *Pongo pygmaeus, Callithrix jacchus* (common marmoset) and *Pan troglodytes* (common chimpanzee) ([Figure 2d](#fig2){ref-type="fig"} for genomic location on chromosome X) (Appendix 1 for methodology of in silico analysis towards verification of miR-934 species conservation and [Supplementary file 3](#supp3){ref-type="supplementary-material"} for the respective results).

In order to define the expression pattern of miR-934, we analyzed a total of 58 small RNA-Seq libraries from various human tissues and cell samples (detailed in [Supplementary file 4](#supp4){ref-type="supplementary-material"}). The analysis confirmed a distinct expression signature for miR-934 which associates predominantly with neural tissues, particularly fetal cortical tissues ([Figure 2e](#fig2){ref-type="fig"} and [Appendix 1---figure 1](#app1fig1){ref-type="fig"} for non-neural tissue assessment). Specifically, a recent study reported consistent expression of miR-934, even if at low levels, during cortical development at 16.5--19.5 gestational week (GW) ([@bib59]; [Figure 2e](#fig2){ref-type="fig"}). According to meta-analysis of available data, we attest that miR-934 expression is undetectable in the adult nervous system ([Figure 2e](#fig2){ref-type="fig"}). Moreover, in agreement with our results, there is no expression of miR-934 in publicly accessible miRNA data from samples of embryonic stem cells and differentiated neurons ([Supplementary file 4](#supp4){ref-type="supplementary-material"} and [Figure 2f](#fig2){ref-type="fig"}). These findings further corroborated the tissue- and stage-specific expression of miR-934 and prompted us to investigate further its function.

miR-934 controls the balance between Pax6+ progenitors and DCX+ neuroblasts and affects the morphological transition of newly born neurons {#s2-3}
------------------------------------------------------------------------------------------------------------------------------------------

To gain insight into the physiological role of miR-934 in early human neural development, we examined the functional consequences of miR-934 modulation at the stage of neural induction of hESCs in vitro, using synthetic miRNA mimics or inhibitors to enhance mature miR-934 expression or block its function, respectively. Gain-of-function of miR-934 created a shift towards neurogenesis with the generation of an increased number of DCX+ neuroblasts/early neurons by 41.8% and a simultaneous reduction of PAX6+ progenitors by 39.4% ([Figure 3a--d](#fig3){ref-type="fig"} and quantification in [Figure 3o,p](#fig3){ref-type="fig"}). Conversely, inhibition of miR-934 action enhanced the number of PAX6+ precursors by 39.5%, while decreasing the levels of DCX+ neuroblasts/early neurons by 27.8% ([Figure 3e--h](#fig3){ref-type="fig"} and quantification in [Figure 3q,r](#fig3){ref-type="fig"}). This data suggests that miR-934 acts at the progenitor to neuroblast switch to promote differentiation.

![Perturbation of miR-934 affects the balance between Pax6+ progenitors and DCX+ neuroblasts and impacts on the morphological transition of newly born neurons.\
(**A--H**) Representative confocal images of hESC-derived cultures at neural induction stage (DIV12) following immunolabeling for Pax6 (green) and Nestin (red) or for doublecortin (DCX, green), upon miR-934 overexpression or inhibition, as indicated. Cell nuclei were visualized with Hoechst (blue). Scale bar = 100 μm. (**O, P**) Overexpression of miR-934 resulted in a reduction of the percentage of PAX6+ progenitors out of all cells in culture (CT mimics: 100 ± 9.9 and miR934 mimics: 60.6 ± 9.2, p=0.04, n = 3) and an increase of the percentage DCX+ neuroblasts out of all cells in culture (CT mimics: 100 ± 6.1 and miR934 mimics: 141.8 ± 5.6, p=0.007, n = 3). (**Q, R**) Inhibition of miR-934 has the opposite effect (for PAX6+% cell quantification: CT inhibitors 100 ± 7.2 and miR934 inhibitors 139 ± 9.6, p=0.01, n = 5; for DCX+% cell quantification: CT mimics 100 ± 7.6 and miR934 inhibitors 72.2 ± 6.5, p=0.02, n = 5--6). (**I--J, L--M**) Representative confocal images following immunolabeling for DCX (green) and TUJ1 (red) of control cultures at neural induction (DIV12) or upon miR-934 inhibition. Scale bar = 100 μm. TUJ1+ cells in white insets in (**J, M**) are shown at higher magnification in (**K, N**), respectively. Scale bar = 50 μm. Measurements performed were based on TUJ1 expression: Inhibition of miR-934 during neural induction affects the morphology of newly-born neurons leading to (**S**) reduction of the length of the longest TUJ1+ neurite (μm): for control inhibitors (CT) 109.78 ± 14. 2 vs. 54.53 ± 2.8 for miR-934 inhibitors; p=0.02, n = 4, 280 cells and (**T**) to decreased number of TUJ1+ neurons exhibiting a bipolar phenotype (% bipolar neurons over total neurons analyzed for control CT inhibitors: 55.9 ± 3.1 vs. 34.4 ± 1.1 for miR-934 inhibitors; p=0.003, n = 4, 160 cells). Bars and error bars represent mean values and the corresponding SEMs; 0.01\<\*p\<0.05; 0.001\<\*\*p\<0.01.\
Figure 3---source data 1.Data on estimation of % Relative PAX+ and DCX+ cells.\
Figure 3---source data 2.Data on measurements of Longest Process in TUJ1+ neurons and of % of bipolar TUJ1+ neurons.](elife-50561-fig3){#fig3}

As neuronal birth and differentiation are tightly linked processes, we next assessed the effect of miR-934 on the morphology of newly born neurons. We evaluated the length of the longest βΙΙΙ-tubulin+ process as a measure of neurite outgrowth and the acquisition of a bipolar shape as an indication of neuronal morphological transition ([@bib66]). Measurements on DCX-positive neurons co-expressing the neuronal marker βIII-tubulin (TUJ1) revealed a 50% reduction in the length of the longest TUJ1+ neurite \[[Figure 3i--n,s](#fig3){ref-type="fig"}; p=0.02\], and a 40% decrease in TUJ1+ bipolar cells ([Figure 3i--n,t](#fig3){ref-type="fig"}; p=0.003) due to miR-934 inhibition. These results indicate that miR-934 controls neuronal birth and influences tightly linked differentiation processes in newborn neurons.

The mRNA targets of miR-934 during neural induction are associated with progenitor proliferation and neuronal differentiation {#s2-4}
-----------------------------------------------------------------------------------------------------------------------------

To locate mRNA targets of miR-934 we explored the RNA-seq data obtained upon transition from hESCs/iPSCs to NPCs, as well as a second set of RNA-seq data generated at the stage of neural induction of hESCs following sustained inhibition of miR-934 function via transduction with the miRZip lentivector-based anti-microRNA system. To identify miR-934 targets in each case, we integrated small RNA and RNA sequencing data using the algorithm presented in mirExTra v2 ([@bib82]). Targets were detected using microT-CDS target prediction tool as the source of potential interactions ([@bib64]; [Supplementary file 5](#supp5){ref-type="supplementary-material"}).

The identified miR-934 targets comprise Frizzled 5 (FZD5) (microT-CDS prediction score 0.85), a member of the \'frizzled\' gene family of receptors for Wnt signaling proteins, TFCP2L1 (microT-CDS prediction score 0.796), a stem cell self-renewal factor ([@bib88]), as well as STMN2 (stathmin-2, SCG10) (microT-CDS prediction score 0.853) and RAB3B (microT-CDS prediction score 0.755), which are implicated in neurite outgrowth and neurotransmission ([@bib71]; [@bib75]; [Supplementary file 5](#supp5){ref-type="supplementary-material"}). We confirmed by qRT-PCR that sustained inhibition of miR-934 during neural induction up-regulates the four predicted targets FZD5, TFCP2L1, STMN2, and RAB3B ([Figure 4a--b](#fig4){ref-type="fig"}). The in silico analysis also predicted F11R a junctional adhesion molecule ([@bib60]; [@bib77]; [@bib24]) and SLC16A1 a monocarboxylate transporter ([@bib29]; [@bib44]) as potential binding partners of miR-934, yet we could not confirm changes in their mRNA expression upon miRNA-934 perturbation ([Supplementary file 5](#supp5){ref-type="supplementary-material"}; [Figure 4a](#fig4){ref-type="fig"}\--b).

![Identification of miR-934 targets during neural induction.\
(**A**) Confocal image showing PAX6+ neural progenitors (red) at DIV 15 transduced with miRZip lentivector (GFP fluorescence, green) for sustained inhibition of miR-934. Scale bar: 20 μm. (**B**) qRT-PCR data showing upregulation of miR-934 targets upon sustained miR-934 inhibition: TFCP2L1 (scrambled control 1[+]{.ul}0.006 vs miR934 inhibition 3.63[+]{.ul}0.67, p=0.03, n = 4), STMN2 (scrambled control 1[+]{.ul}0.003 vs miR934 inhibition 1.95[+]{.ul}0.23, p=0.02, n = 4), RAB3B (scrambled control 1[+]{.ul}0.003 vs miR934 inhibition 2.29[+]{.ul}0.28, p=0.01, n = 4), and FZD5 (scrambled control 1,004[+]{.ul}0005 vs miR934 inhibition 1,44[+]{.ul}0,061, p=0,005, n = 4). No changes were observed in the mRNA expression of F11R or SLC16A1 (p=0,18 for SLC16A1and p=0,47 for F11R, n = 4). (**C**) Sequence complementarity of miR-934 with the 8-mer binding site in Fzd5 3\'-UTR region (green) and corresponding mutated site (blue), used in luciferase activity assay. (**D**) Estimation of the suppression of luciferase activity in HEK293T cells upon co-transfection with miR-934 mimics and the MRE (8-mer binding site) reporter construct. Suppression of luciferase activity was released upon mutation of the FZD5 8mer binding site (p=0.002, n = 3). (**E--G**) Sustained inhibition of miR-934 results in increased protein levels of FZD5 (p=0.007, n = 4) (**E, F**) and active β-catenin (p=0.01, n = 4) (**E, G**). Bars and error bars represent mean values and the corresponding SEMs; 0.01\<\*p\<0.05; 0.001\<\*\*p\<0.01.\
Figure 4---source data 1.qRT PCR data for expression of miR-934 predicted targets upon sustained miR934 inhibition.\
Figure 4---source data 2.Data on luciferase activity in HEK293T cells upon co-transfection with miR-934 mimics and the MRE (8-mer binding site) reporter construct.\
Figure 4---source data 3.Data on western blot results for FZD5 and b-catenin proteins following miR934 Sustained inhibition.](elife-50561-fig4){#fig4}

The putative miRNA recognition elements (MREs) on the 3\'-UTRs of the predicted targets FZD5, TFCP2L1, STMN2, and RAB3B contain binding sites with high probability for functional impact (8mer, 7mer and 9mer binding sites) ([@bib1]). From an evolutionary point, it is worth noting that the identified 8mer binding site for STMN2 is expressed in various species whilst the respective MREs for TFCP2L1 and RAB3B are mainly conserved in primates ([Supplementary file 6](#supp6){ref-type="supplementary-material"}). To validate the bioinformatics data for target prediction we ran luciferase assays to selectively assess the interaction between miR934 and TFCP2L1 or RAB3B. To this end, we cloned regions of their 3'UTRs containing the individual binding sites for each target into the pmiRGLO luciferase reporter vector. Co-transfection of HEK293T cells with each of the modified vectors and miR934 mimics followed by measurement of luciferase activity confirmed the binding of miR934 at specific sites of these mRNAs ([Appendix 1---figure 2](#app1fig2){ref-type="fig"}).

Regarding the two predicted binding regions for miR934 on the 3'UTR for FZD5, the 7mer seed-matched site presents expression in different species while the 8mer seed-matched site is only conserved between human and the common chimpanzee ([Supplementary file 6](#supp6){ref-type="supplementary-material"}). Given the recognized role of Wnt signaling pathway during development and particularly in human progenitor cell proliferation and fate specification ([@bib84]; [@bib87]), we investigated if interaction of miR-934 with FZD5 can differentiate between the species-specific 8-mer and the more widely occurring 7-mer binding site. To this end, we examined independently the binding of miR-934 on each of the two predicted MREs using the pmiRGLO luciferase reporter system and determined that miR-934 indeed targets the 8mer seed-matched site, which is only conserved between human and the common chimpanzee (Appendix 1 for method and [Appendix 1---figure 3](#app1fig3){ref-type="fig"} for results). To validate this interaction, we cloned the respective 29nt-long MRE or its mutated form into the dual luciferase reporter vector ([Figure 4c--d](#fig4){ref-type="fig"}). Co-transfection of miR-934 mimics and the 8mer seed reporter construct suppressed luciferase activity in HEK293T cells by 36% (p=0.002), thus validating and specifying the region of interaction between miR-934 and FZD5 ([Figure 4d](#fig4){ref-type="fig"}).

Finally, we examined the effect of miR-934 on the Wnt pathway using immunoblot analysis ([@bib50]). Sustained inhibition of miR-934 during neural induction resulted in a moderate up-regulation of FZD5 protein and active β-catenin by 29 ± 4.5% and 28.5 ± 5.2% respectively ([Figure 4a,e--g](#fig4){ref-type="fig"}), suggesting that miR-934 acts to suppress β-catenin expression, a downstream effector of the Wnt pathway, by silencing FZD5 expression.

Taken together our data support that miR-934 acts during neural induction to suppress genes implicated in stem cell self-renewal and neurogenesis.

Inhibition of miR-934 during neural induction affects molecular pathways of neurogenesis and alters the expression of subplate-enriched genes {#s2-5}
---------------------------------------------------------------------------------------------------------------------------------------------

To further assess downstream signaling networks affected by miR-934, we examined the RNA profiling of hESC-derived cells at the neural induction phase upon sustained miR-934 inhibition. Differential gene expression analysis provided molecular data corroborating and extending our functional data. Overall miR-934 inhibition resulted in altered expression of 1458 genes (650 upregulated and 810 downregulated; p value\<0.05), which according to GO (Gene Ontology) enrichment analysis (q value \< 0.05) are primarily allocated to biological processes affecting progenitor cell proliferation, differentiation, axonal growth/guidance, neuronal migration, and neurotransmitter transport/release ([Figure 5a](#fig5){ref-type="fig"}). Moreover, the reported miR-934 targets STMN2 and RAB3B, match with the processes revealed by enrichment analysis, conforming to the categories of axonogenesis and neurotransmission ([Figure 5c,e](#fig5){ref-type="fig"}).

![Sustained Inhibition of miR-934 induces global expression changes in genes associated with NPC proliferation and neuronal differentiation.\
(**A**) GO enrichment analysis of differential gene expression data following sustained inhibition of miR-934. (**B--E**) Heatmaps presenting the log2-fold change of molecules involved in the indicated biological processes following miR-934 inhibition, as determined by GO enrichment analysis, from three independent experiments 1, 2 and 3. miR-934 targets STMN2 and RAB3B are depicted in red. (**F**) Heatmap presenting the log2-fold change of progenitor-specific and SP-enriched genes. Warmer colors indicate higher fold changes. (**G**) Graph showing qRT-PCR validation data for genes affected by miR-934 inhibition (n = 3--4): LEF1 (scrambled control 1[+]{.ul}0.0003 vs miR934 inhibition 1.57[+]{.ul}0.09, p=0.009), TFAP2C (scrambled control 1[+]{.ul}0.0006 vs miR934 inhibition 0.75[+]{.ul}0.08, p=0.04), MOXD1 (scrambled control 1[+]{.ul}0.0002 vs miR934 inhibition 0.6[+]{.ul}0.14, p=0.04), ID2 (scrambled control 1[+]{.ul}0.01 vs miR934 inhibition 1.52[+]{.ul}0.14, p=0.03), NCAD (scrambled control 1[+]{.ul}0.002 vs miR934 inhibition 1.75[+]{.ul}0.17, p=0.01), GATA2 (scrambled control 1[+]{.ul}0.01 vs miR934 inhibition 0.75[+]{.ul}0.06, p=0.01), SYNGAP1 (scrambled control 1[+]{.ul}0.0004 vs miR934 inhibition 2.4[+]{.ul}0.33, p=0.02), PRSS12 (scrambled control 1[+]{.ul}0.0002 vs miR934 inhibition 0.67[+]{.ul}0.03, p=0.002) and TPD52L1 (scrambled control 1[+]{.ul}0.0002 vs miR934 inhibition 0.65[+]{.ul}0.07, p=0.03). Bars and error bars represent mean values and the corresponding SEMs; 0.01\<\*p\<0.05.\
Figure 5---source data 1.qRT PCR data for expression of genes affected by miR-934 inhibition.](elife-50561-fig5){#fig5}

In terms of precursor-to-neuron differentiation, miR-934 inhibition coincides with up-regulation of N-Cadherin, which promotes self-renewal of NPCs ([@bib59]), induction of ID2 (inhibitor of DNA binding protein 2) that inhibits differentiation and promotes proliferation ([@bib63]), and reduction of GATA2, a transcription factor essential for neurogenesis ([@bib23]; [Figure 5b,g](#fig5){ref-type="fig"}). With respect to axonal development, we detected miR-934-driven dysregulation of SYNGAP1 expression, an essential repressive factor involved in neuronal differentiation by controlling the timing of dendritic spine synapse maturation ([@bib37]; [@bib72]; [@bib80]; [Figure 5c,g](#fig5){ref-type="fig"}). We also observed dysregulation of genes associated with tract formation and pathfinding, including molecules that belong to the semaphorin -- neuropilin -- plexin pathway, of their downstream intracellular mediators CRMPs (collapsing response mediator proteins), and also Ephrins and ROBOs ([Figure 5c](#fig5){ref-type="fig"}; [@bib68]). Moreover, there were deviations in expression of the Neuregulin-1/ErbB4 signalling partners, as well as of Reelin, the stimulus-regulated transcription factor Serum Response Factor (SRF) and the extracellular matrix protein matrilin 2, which are involved in neuronal migration ([@bib73]; [Figure 5d](#fig5){ref-type="fig"}). Proteins linked to neurotransmitter release that were affected include Snapin and members of Syntaptotagmin family ([Figure 5e](#fig5){ref-type="fig"}). Verification by qRT-PCR of the differential expression of selected genes is shown in [Figure 5g](#fig5){ref-type="fig"}.

Regarding cellular identities, analysis of differential data revealed altered expression of genes including TCFAP2C, MOXD1 and LEF1, a Wnt downstream target ([@bib6]) that characterize dorsal telencephalic radial glia and apical progenitors, as recently reported in single cell RNA-seq profiling of human fetal brain ([@bib59]; [@bib26]; [@bib58]; [Figure 5f](#fig5){ref-type="fig"} and validation by qRT-PCR in [Figure 5g](#fig5){ref-type="fig"}; [Supplementary file 8](#supp8){ref-type="supplementary-material"}). On the other hand, we did not observe differences in the expression of the transcription factor Tbr2 (EOMES) that characterizes intermediate progenitors and which was found in particularly low abundance, or the outer radial glia marker HOPX ([@bib67]; [Appendix 1---figure 4a](#app1fig4){ref-type="fig"}). Moreover, there were no changes in ventral or mid-brain fate specification markers, including DLX1, DLX2, ALSC1, PAX2 and GBX2 which all exhibited lower expression as compared to the dorsal forebrain marker EMX2 ([@bib3]; [@bib11]; [@bib32]; [@bib19]; [Appendix 1---figure 4b](#app1fig4){ref-type="fig"}). Of interest, we did not detect expression of early markers of lateral and medial ganglionic eminences, such as Nkx2.1, GSX1 and GSX2 with or without miR-934 perturbation ([@bib9]; [@bib65]).

To determine the developmental stage involved, we compared differential RNA expression data for genes that characterize the molecular profile of prodromal/pioneer neuronal populations during cortical development. We detected low expression in a series of early neuronal markers, while further analysis did not reveal miR-934-mediated differences in the expression of genes characterizing deep layer neurons, such as FEZF2, TBR1, FOXP2 and CTIP2 (BCL11B), or the early fate determinant of upper layer neurons CUX2 ([@bib56]; [Appendix 1---figure 4a](#app1fig4){ref-type="fig"}). We detected expression of SATB2 which is reported to be co-expressed with CTIP2 in a subset of early neurons of the visual cortex ([@bib58]; [@bib92]), yet this transcription factor presented no change upon miR-934 perturbation ([Appendix 1---figure 4a](#app1fig4){ref-type="fig"}).

We next examined subplate-associated genes as the SP is a major site of neocortical neurogenesis containing some of the earliest born neurons. For this comparison we assessed a series of subplate-enriched molecular markers with reference to the RNA-seq dataset generated by Miller et al from human fetal brain at gestational weeks 15 and 16 ([@bib55]; [Supplementary file 8](#supp8){ref-type="supplementary-material"}; [Figure 5f](#fig5){ref-type="fig"}). We observed alterations in 19 subplate-enriched genes, including two genes PRSS12 and TPD52L1 identified by [@bib34]; [@bib52] that were validated by qRT-PCR ([Figure 5g](#fig5){ref-type="fig"}).

Finally, miRNA profiling showed significant changes in 79 miRNAs (p value\<0.05) in response to miR-934 inhibition. Bibliographic examination of the 20 differentially expressed miRNAs exhibiting the lowest p values revealed their association with axon/neurite growth and synapse formation ([Figure 6a,b](#fig6){ref-type="fig"}). Further we identified miR-34c-5p, which plays an important role in neurogenesis and brain development ([@bib24]; [@bib85]), as a crucial regulator downstream of miR-934, and confirmed by RT-qPCR its reduction in response to miR-934 inhibition ([Figure 6c](#fig6){ref-type="fig"}; p=0.004. n = 4).

![miRNA expression profiling following sustained inhibition of miR-934.\
(**A**) Heatmap showing the 20 miRNAs with lowest p-values at differential expression analysis following miR-934 sustained inhibition. (**B**) Table describing the association of differentially expressed miRNAs with axon/dendrite development and/or synapse formation. miRNA associations taken from [@bib24]; [@bib85]; [@bib15]; [@bib16]; [@bib27]; [@bib31]; [@bib46]; [@bib45]; [@bib69]; [@bib70]; [@bib86]. (**C**) qRT-PCR showing downregulation of mir34c-5p following miR-934 sustained inhibition (scrambled control 1[+]{.ul}0.005 vs miR934 inhibition 0.51[+]{.ul}0.03, n = 3, p=0.005). Bars and error bars represent mean values and the corresponding SEMs; 0.001\<\*\*p\<0.01. (**D**) Sketch depicting the neurogenic function of miR-934 also affecting subsequent neuronal differentiation processes as reflected in large-scale changes in the expression of genes and miRNAs associated with neurogenesis.\
Figure 6---source data 1.qRT-PCR data for expression of miR-34c-5p following miR-934 sustained inhibition.](elife-50561-fig6){#fig6}

This data highlights the role of miR-934 in modulating molecular pathways mediating neurogenic events associated with early dorsal progenitor populations and the subplate zone.

Discussion {#s3}
==========

Identification of species-specific features is critical in order to delineate spatiotemporal events during neural development, a process that underlies the complexity in organization and function of the human brain, and which may further convey the origin of neurodevelopmental or neuropsychiatric pathologies. Using an in vitro model of neural development, we identified here miR-934 as a novel species-specific regulator of early human neurogenesis. miR-934 displays a developmental stage-specific expression pattern during neural induction that is characterized by neural progenitor expansion and early neuron generation. Our functional analysis revealed that it acts at the precursor-to-neuron transition to induce the differentiation of neural progenitors. The neurogenic function of miR-934 was further confirmed by large-scale changes in the expression of protein-coding and miRNA genes associated with progenitor cell proliferation and differentiation, neuritic growth and neurotransmission. The involvement of the identified miR-934 targets in these processes suggests a direct link between miR-934 function and the signalling networks mediating the neuronal differentiation program ([Figure 6d](#fig6){ref-type="fig"}).

Here we report four miR-934 targets during neural induction, namely TFCP2L1, FZD5, STMN2 and RAB3B. The direct downstream implications of miR-934 on post-transcriptional control of gene expression may be even broader since miRNAs, besides causing mRNA degradation, may also act to inhibit translation of their mRNA targets thus affecting expression at the protein level. The identified targets of miR-934 play a role in diverse processes along the neurogenic program including stem cell self-renewal, neural progenitor proliferation and differentiation as well as cytoskeletal arrangement and neurotransmission. It is therefore conceivable that miR-934-mediated modulation in the expression of these molecules should further influence downstream pathways related to morphological and functional transition of neural progenitor cells, thus causing an amplification in gene expression changes. Consistently, we observed altered expression in a total of 1458 genes upon miR-934 inhibition.

We present mechanistic and functional evidence that during neural induction miR-934 targets the Wnt receprtor FZD5 to suppress active β-catenin. Genetic ablation of FZD5 has previously been associated with increased generation of early-born retinal neurons and accelerated neurogenesis in the mouse ([@bib49]). In line, β-catenin signaling hinders neuronal differentiation to promote progenitor cell proliferation during neurogenesis ([@bib84]), while recently the Wnt/β-catenin pathway has been implicated in acquisition of early neural regional identities ([@bib87]). Transcriptome profiling further supported the role of miR-934 in progenitor function by revealing altered expression of molecules that favor progenitor proliferation including N-cadherin, which liaises with β-catenin at adherens junctions to maintain NPC morphology and self-renewal ([@bib91]).

Differential gene expression analysis upon miR-934 inhibition revealed the microtubule destabilizing protein Stathmin 2, a powerful modulator of microtubule dynamics as a target of miR-934 ([@bib30]). The dynamic assembly and disassembly of microtubule cytoskeleton can dramatically impact on neurite/axonal outgrowth and placement of neurons ([@bib28]), suggesting that the dysregulated expression of STMN2 contributes to the aberrant neuronal morphology noted here upon perturbations in miR-934 expression. In support, enrichment analysis further revealed negative regulation of cell adhesion and highlighted the involvement of permissive and repulsive cues required for axon--dendrite orientation, proper tract formation and neuronal positioning. These include semaphorins, their receptors neuropilins and plexins, and also Ephrins which are all components of the dynamic intrinsic--extrinsic process affecting axon outgrowth and guidance, and the bipolar transition required for radial migration of neurons during early development ([@bib68]; [@bib14]; [@bib20]; [@bib79]).

In order for migrating neurons to respond to neurotransmitter-mediated signaling, specific organization of the neuronal cytoskeleton is required to permit selective transport of synaptic vesicles and neurotransmitter receptors to axons or dendrites ([@bib33]). Thus, the effect of miR-934 on neurotransmitter release may be considered as a consequence of abnormal neuritogenesis/axonogenesis and impaired microtubule dynamics. Interestingly, Rab3B, another identified target for miR-934 in this system, acts as a modulator of the neurotransmitter release machinery ([@bib75]), while its overexpression results in inhibition of neurotransmitter secretion ([@bib74]). Accordingly, perturbation of miR-934 results in altered expression of proteins implicated in the tight coupling of exo-endocytosis of synaptic vesicles, including Snapin and members of the synaptotagmin protein family (Syt11, Syt7) ([@bib13]; [@bib54]; [@bib83]).

An intriguing finding is the upregulation of SYNGAP1 in response to miR-934 inhibition. SYNGAP1 is localized in excitatory neurons ([@bib37]) and acts as an essential repressive factor to control the timing of dendritic spine synapse maturation ([@bib72]; [@bib80]). Moreover, SYNGAP1 has been associated with intellectual disability and autism spectrum disorders as its disruption affects the excitation/inhibition balance in neural networks that support cognition and behavior. Thus miR-934-mediated regulation of SYNGAP1 insinuates a link between early developmental events and shaping of connectivity at later stages, including integration of excitatory and inhibitory input ([@bib43]).

Consistent with the timing of miR-934 expression, positioned at an early neurodevelopmental period, we noted alterations in the expression of genes associated with the subplate, a region containing some of the earliest born cortical neurons (reviewed in [@bib52]). During early development the structure and function of the cerebral cortex seems to be critically organized by SP neurons, a mostly transient heterogeneous population located below the cortical plate. SP neurons are indispensable during a restricted phase of development, contributing to refinement of the thalamocortical innervation, while it has been reported that the SP has the capacity to modulate projection neuron fate ([@bib62]). Already at GW9--GW10 in humans, the upper half of this compartment expresses markers that are characteristic of synaptic connectivity and axonal outgrowth ([@bib35]).

In view of our collective functional and molecular data, miR-934 emerges as a regulator of early human neurogenesis instigating key transcriptional networks controlling progenitor cell proliferation and neuronal birth and differentiation, modulating the molecular profile of the SP zone. Our data are further complemented by differential expression of a distinct group of miRNAs also involved in neural progenitor proliferation or axon/neurite development and synapse formation. Further research on the function of species-specific miRNAs will advance our understanding on the mechanisms that control spatiotemporal events during human neurodevelopment, a process that dictates neuronal subtype specification, localization, and connectivity securing the integrity of higher cognitive functions.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\              Designation                                     Source or reference                                                                                                                                                                                             Identifiers                                                    Additional information
  (species) or resource                                                                                                                                                                                                                                                                                                                                     
  -------------------------- ----------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cell line (*H. sapiens*)   hESC line HUES6                                 Cowan CA, Klimanskaya I, McMahon J, Atienza J, Witmyer J, Zucker JP, et al. Derivation of embryonic stem-cell lines from human blastocysts. The New England journal of medicine. 2004;350 ([@bib57]):1353--6.   RRID:[CVCL_B19](https://scicrunch.org/resolver/CVCL_B19)       Cell line (*H. sapiens*)

  Chemical compound, drug    Knockout Serum Replacement (KSR)                Life Technologies Thermo Fisher                                                                                                                                                                                 Life Technologies, Thermo Fisher\                              
                                                                                                                                                                                                                                                                                             10828--010                                                     

  Chemical compound, drug    KnockOut DMEM medium                            Life Technologies Thermo Fisher                                                                                                                                                                                 Life Technologies, Thermo Fisher\                              
                                                                                                                                                                                                                                                                                             10829--018                                                     

  Chemical compound, drug    matrigel matrix                                 BD biosciences                                                                                                                                                                                                  BD 354234                                                      See Materials and methods

  Chemical compound, drug    Noggin                                          R and D Systems                                                                                                                                                                                                 R and D 6057 NG-25                                             See Materials and methods

  Chemical compound, drug    SB431542                                        Tocris Biosciences                                                                                                                                                                                              Tocris Biosciences 1614                                        See Materials and methods

  Commercial assay or kit    RNA Clean and Concentrator kit                  Zymo Research                                                                                                                                                                                                   Zymo Research R1018                                            

  Recombinant DNA reagent    pmiR-GLO reporter vector                        Promega                                                                                                                                                                                                         Promega E1330                                                  

  Recombinant DNA reagent    miRZip lentivector-based anti-microRNA system   Systems Biosciences                                                                                                                                                                                                                                                            <https://systembio.com/products/mirna-and-lncrna-research-tools/mirzip-knockdown-vectors/mirzip-anti-mirna-constructs/>

  Chemical compound, drug    Lipofectamine 2000                              Life Technologies/Thermo                                                                                                                                                                                        Life Technologies11668--019                                    

  Sequenced-based reagent    miR-934 mimics                                  Exiqon/Qiagen                                                                                                                                                                                                                                                                  <http://www.exiqon.com/ls/Pages/ProductDetails.aspx?ProductId=k1WVIuhVVQH848C13pCVyN5WGs82ItaE%2flSNAGCdK1%2bEWkr83WchdvRAbgzMNpIk3WDIx9O1eBJZUcYGe81LzgTaw2jJcGjXgRYNy58buck%3d&CategoryType=2yRAQGj8eprRK3%2bx8lE0zg%3d%3d>

  Sequenced-based reagent    miR-934 inhibitors                              Dharmacon                                                                                                                                                                                                                                                                      <https://horizondiscovery.com/products/gene-modulation/knockdown-reagents/mirna/PIFs/miRIDIAN-microRNA-Hairpin-Inhibitor?nodeid=mirnamature-mimat0004977>

  Antibody                   mouse monoclonal anti-PAX6                      Developmental Studies Hybridoma Bank                                                                                                                                                                            RRID:[AB_528427](https://scicrunch.org/resolver/AB_528427)     Dilution (1:50)\
                                                                                                                                                                                                                                                                                                                                                            See Materials and methods

  Antibody                   goat polyclonal anti-doublecortin (DCX)         Santa Cruz                                                                                                                                                                                                      Sc-8067                                                        Dilution (1:100)\
                                                                                                                                                                                                                                                                                                                                                            See Materials and methods

  Antibody                   rabbit polyclonal anti-Frizzled 5               Abcam                                                                                                                                                                                                           Ab75234                                                        Dilution (1:1000)\
                                                                                                                                                                                                                                                                                                                                                            See Materials and methods

  Antibody                   rabbit monoclonal anti-active β-catenin         Cell signaling                                                                                                                                                                                                  Cell signaling, 19807                                          Dilution (1:1000)\
                                                                                                                                                                                                                                                                                                                                                            See Materials and methods

  Software, algorithm        ImageJ                                          ImageJ (<http://imagej.nih.gov/ij/>)                                                                                                                                                                            RRID:[SCR_003070](https://scicrunch.org/resolver/SCR_003070)   

  Sequenced-based reagent    RT-qPCR primers                                 This paper                                                                                                                                                                                                                                                                     See [Supplementary file 7](#supp7){ref-type="supplementary-material"}
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

hESC and iPSC culture {#s4-1}
---------------------

We have used the hESC line HUES6, which has been tested and shown free of mycoplasma contamination. The hESC line HUES6 (46XX) was kindly provided by Douglas Melton at Harvard University ([@bib17]); iPSC lines \[C1-1 and C1-2 clones derived from skin fibroblasts of a male healthy donor and PD1-1 and PD1-2 clones derived from skin fibroblasts of a male patient with familial Parkinson's disease (PD) carrying the G209A (p.A53T) mutation in the α-synuclein gene SNCA\] were generated and characterized as previously described ([@bib39]). HUES6/iPSC lines were cultured on irradiated mouse embryonic fibroblasts (MEFs, Globalstem) in HUES/iPSC medium consisting of KnockOut DMEM (KO-DMEM, Life Technologies), 20% Knockout Serum Replacement (KSR, Life Technologies), 2 mM GlutaMax, MEM Non-Essential Amino Acids (100x MEM NEAA, Life Technologies), 100 mM β-mercaptoethanol (Life Technologies) and 10 ng/ml human basic FGF2 (bFGF2, Miltenyi).

Neural induction of hESCs/iPSCs {#s4-2}
-------------------------------

A schematic summary of the differentiation procedure is shown in [Figure 1a](#fig1){ref-type="fig"}. Cultures were disaggregated using accutase (Life Technologies) for 10 min at 37°C, collected in hESC/iPSC medium supplemented with 10 µM ROCK inhibitor Y-27632 (Tocris Bioscience) in the absence of bFGF-2 (embryoid body/EB medium) and replated in 60 mm petri dishes to allow embryoid body formation for 5--6 days. For neural induction, floating embryoid bodies were collected by centrifugation, dissociated to single cells with accutase for 20 min at 37°C, and plated at a density of 50,000--65,000 cells/cm^2^ on Matrigel (BD)-coated glass coverslips in a 24-well plate. Neural induction was achieved by dual suppression of the SMAD signaling pathway using a combination of Noggin (250 ng/ml; R and D Systems) and SB431542 (10 µM; Tocris Bioscience) in 1:1 mixture of Dulbecco's modified Eagle's medium with high glucose content (DMEM) and F-12, containing HEPES buffer (8 mM; Invitrogen), N2 supplement, and Glutamax (Gibco).

Neuronal differentiation protocol {#s4-3}
---------------------------------

For neuronal differentiation, NPCs generated during the neural induction phase were dissociated with accutase and plated onto poly-L-ornithine (PLO; 20 µg/ml; Sigma-Aldrich)/laminin (5 µg/ml; Sigma-Aldrich)-coated coverslips. Neuronal differentiation was initiated for 8 days in Neurobasal medium supplemented with ascorbic acid (AA, Sigma-Aldrich; 200 μM), human recombinant sonic hedgehog (SHH, R and D Systems; 200 ng/ml), recombinant fibroblast growth factor 2b (FGF-2b, R and D Systems; 10 ng/ml), recombinant fibroblast growth factor 8b (FGF-8b, R and D Systems; 100 ng/ml), containing also 1% N2 supplement, 2% B-27 supplement and 1% Glutamax, followed by a cocktail consisting of brain-derived neurotrophic factor (BDNF, R and D Systems; 20 ng/ml), ascorbic acid (200 μM), glial cell-derived neurotrophic factor (GDNF, R and D Systems; 10 ng/ml), and cyclic-AMP (cAMP, Sigma-Aldrich; 0.5 mM) for further 21--26 days to allow neuronal maturation.

RNA isolation, cDNA Synthesis and RT-qPCR {#s4-4}
-----------------------------------------

Total RNA, including miRNAs, was extracted from cell pellets at different time points of neural induction, using TRIzol Reagent (Life Technologies). Residual DNA was degraded with DNase (Takara) for 30 min at 37°C and purified RNA was recovered using the RNA Clean and Concentrator kit (Zymo Research). 1 µg of total RNA was used for first-strand cDNA synthesis which was performed using the PrimeScript RT reagent Kit (Takara). miRNA first-strand cDNA synthesis (from 10 ng RNA) was performed using the Universal cDNA synthesis kit (Exiqon). In all cases, commercially available kits were used according to manufacturer\'s instructions. Quantitative reverse transcription polymerase chain reaction (RT--qPCR) was carried out on a ViiA-7 real time PCR instrument (Applied Biosystems) according to the manufacturer's instructions. For mRNA expression detection, the RT--qPCR reactions were prepared with SYBR Green PCR Master mix (Kapa biosystems). LNA primer sets designed by Exiqon were used for miRNA expression detection and the RT--qPCR reactions were prepared with ExiLENT SYBR Green master mix (Exiqon). GAPDH and hsa-miR-103a-3p were used as reference genes. All primers used are listed in [Supplementary file 7](#supp7){ref-type="supplementary-material"}.

Generation of genome-wide RNA sequencing data {#s4-5}
---------------------------------------------

RNA sequencing was performed at specific stages of hESC/iPSC directed differentiation and also upon sustained inhibition of miR-934 during neural induction of hESCs (NPC stage). In the first series of experiments, total cellular RNA isolated from samples at specific stages of the differentiation procedure ([Figure 1a](#fig1){ref-type="fig"}) corresponded to hESCs, hESC-derived NPCs (13 DIV) and neurons (48 DIV) alongside iPSCs, iPSC-derived NPCs and neurons cultured for the same DIV. Total RNA from two control iPSC lines (C1-1 and C1-2) derived from a healthy donor and two lines (PD1-1 and PD1-2) from a PD patient ([@bib39]). The originating fibroblasts as well as human fetal fibroblasts (Human Dermal Fibroblasts, foreskin, fetal; Cell Applications) were analyzed. In the second series, total RNA was isolated from three independent experiments of hESC-derived NPCs (15 DIV) transduced with an anti-miR-934 lentivirus or the scrambled control virus at DIV 10 of neural induction and collected 5 days later. Libraries of RNA transcripts following polyA selection were prepared using TruSeq RNA Sample Preparation Kit V2 (Illumina). Small RNA libraries were prepared using NEBNext Multiplex Small RNA Library Prep Set for Illumina. Next generation sequencing of RNAs (50 bp, paired-end) and small-RNAs (50 bp, single-end) was performed using an llumina HiSeq 2500 sequencer at the European Molecular Biology Laboratory (EMBL).

Quantification and integration of expressed microRNAs and mRNAs {#s4-6}
---------------------------------------------------------------

More than 2 billion reads were obtained from the performed sequencing experiments. All sequencing libraries were quality checked using FastQC ([www.bioinformatics.babraham.ac.uk/projects/fastqc/](http://www.bioinformatics.babraham.ac.uk/projects/fastqc/)). Contaminant detection and pre-processing was performed using a combination of in-house scripts and available tools ([@bib82]). RNA-Seq reads from the miR-934 activity inhibition experiments were aligned against GRCh38 human genome using STAR ([@bib21]) and quantified with featureCounts ([@bib47]) against Ensembl v89. microRNA expression was quantified using miRDeep2 ([@bib53]). A gene/miRNA expression model encompassing the independent experiment number (i.e. 1, 2, 3) as a factor was built using DESeq2 ([@bib51]). RNA-Seq from the differentiation stages were analyzed as previously ([@bib39]). Differential expression analysis of miRNAs and RNAs across differentiation stages was performed using DESeq package in R ([@bib2]). Functional analyses were performed using ClusterProfiler package ([@bib90]). miR-934 expression across tissues was obtained by analyzing in-house 58 small RNA-Seq libraries from NCBI SRA repository with the same pipeline mentioned above for consistency. The accession IDs from the specific samples are indexed in [Supplementary file 4](#supp4){ref-type="supplementary-material"}. Validation of the differential expression for selected genes and miRNAs from the RNA-Seq analysis was performed by qRT-PCR in independent samples.

In silico miRNA target prediction was performed using DIANA-microT-CDS ([@bib64]), while the detection of pathways regulated by differentially expressed miRNAs was realized using DIANA-miRPath v2.1 ([@bib81]). Integration of small RNA-Seq and RNA-Seq expression data for the detection of miRNAs with central regulatory roles was performed with a local deployment of DIANA-mirExTra v2 ([@bib82]). The following settings were utilized in the analysis: miRNA/RNA DE threshold: FDR \< 0.05, microT-CDS prediction threshold: 0.7, DE method: DESeq.

In heatmaps, Pearson's correlation coefficient was used as a distance metric, while in the correlation plots the Euclidian distance between Pearson's correlation coefficients was employed for clustering. Expression Heatmap data were centered and scaled using row Z-scores. Fold-Change heatmaps were not centered/scaled or clustered; the column order follows the independent experiment number.

Calculation of tissue-specificity-index tau for miRNAs across distinct differentiation stages {#s4-7}
---------------------------------------------------------------------------------------------

Tau was calculated on log2 (reads per million) values according to the recommended transformation ([@bib42]). miRNAs with tau \>0.7 were selected as having highly specific expression signatures (n = 144), that is exhibiting disproportionally high expression in a single or few stages, while low or non-detectable in most other stages. The 144 miRNAs were subsequently ranked for median expression in NPCs in order to locate miRNAs with high and specific expression at the NPC stage.

3\'-UTR dual luciferase assay {#s4-8}
-----------------------------

For cloning the 29nt long Fzd5 8-mer MRE, commercially available sense and anti-sense oligos (Eurofin) were annealed and inserted into the 3\'-UTR of the pmiR-GLO reporter vector at the NheI and XbaI restriction sites. Oligos used for cloning are listed in [Supplementary file 7](#supp7){ref-type="supplementary-material"}. Clones were verified by sequencing analysis. HEK293T cells were co-transfected with the modified constructs and miRNA mimics (100 nM, Exiqon/Qiagen) and luciferase activity was measured 48 hr later with the Promega Luciferase assay system.

Transduction with miRZip lentivirus for sustained miR-934 inhibition {#s4-9}
--------------------------------------------------------------------

Sustained inhibition of miR-934 during neural induction was achieved with the miRZip lentivector-based anti-microRNA system (Systems Biosciences). hESC cultures were transduced with the anti-miR-934 lentivirus or the scrambled control virus at DIV10 of neural induction and were collected for analysis 5 days later at DIV15. Samples were then examined by RNA sequencing, qRT-PCR or wWestern blot.

Transfection with miRNA mimics or inhibitors {#s4-10}
--------------------------------------------

hESC cultures at neural induction stage were transiently transfected with Lipofectamine 2000 (Life Technology) in Optimem (ThermoFisher Scientific) according to the manufacturer's instructions. Cells were incubated in transfection mix overnight before fresh medium was added. A scrambled miRNA, which bears no homology to any known miRNA sequences in human, mouse or rat, was used as control. In a first set of experiments, 3 doses of miR-934 mimics (100 nM, Exiqon) or inhibitors (100 nM, Dharmacon) were applied at DIV6, DIV8 and DIV10 and the cultures were analyzed 2 days later at DIV12. Cells were either fixed or collected with Accutase and the cultures were analyzed by immunocytochemistry and/or RT-qPCR.

Immunocytochemistry and confocal microscopy {#s4-11}
-------------------------------------------

Cultures were fixed at the indicated time points in 4% w/v paraforlmadehyde for 20 min, washed with phosphate-buffered saline (PBS), blocked and permeabilized with 5% donkey serum in PBS containing 0.1% Triton X-100. The following primary antibodies were used: mouse monoclonal anti-PAX6 (1:50, Developmental Studies Hybridoma Bank) to identify neural progenitors; rabbit polyclonal anti-Nestin (1:200, Millipore) to identify neuroepithelial cells; goat polyclonal anti-doublecortin (DCX, 1:100; Santa Cruz) to identify neuroblasts/early neurons; rabbit polyclonal βIII-tubulin (TUJ-1 antibody 1:1000, Cell Signaling) to identify neurons; and goat polyclonal anti-Nanog (1:100, R and D) to identify pluripotent cells. After incubation with appropriate secondary antibodies conjugated with AlexaFluor 488 (green) or 546 (red) (1:500; Molecular Probes, Eugene, OR, USA), coverslips were mounted with ProLong Gold antifade reagent with DAPI (Cell Signaling). For quantification of labeled cells, images from 10 randomly selected fields from each independent experiment were obtained using a 20X lens on a Leica TCS-SP5II confocal microscope (LEICA Microsystems) and analyzed using ImageJ software (NIH).

Western blot analysis {#s4-12}
---------------------

Cells were harvested, lysed at 4°C for 30 min in ice cold RIPA buffer containing PhosSTOP phosphatase inhibitors and a complete protease inhibitor mixture (Roche Life Science), and centrifuged at 20,000 g for 15 min. Protein concentration in the supernatant was estimated using the Bradford assay (Applichem). Proteins (50 μg) were separated by 10% SDS--PAGE electrophoresis and transferred onto nitrocellulose membranes (Trans-Blot, Biorad). Non-specific binding sites were blocked in Tris-buffered saline (TBS/0.1% Tween-20) containing 5% skimmed milk for 30 min at 37°C. Membranes were probed with the following primary antibodies: rabbit polyclonal anti-Frizzled 5 (1:1000, abcam), rabbit monoclonal anti-active β-catenin (1:1000, cell signaling), anti-Actin (1:1000, Millipore), and mouse monoclonal anti-GAPDH (1:1000, Santa Cruz). Immunodetection was performed by chemiluminescence (ECL) using the Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare) and quantification was performed against GAPDH and also verified against Actin.

Morphological analysis of TUJ1+/DCX+ neurons {#s4-13}
--------------------------------------------

The outgrowth of the longest TUJ1+ process, and the percentage of neurons exhibiting a bipolar phenotype were estimated for TUJ+/DCX+ neurons in neural induction cultures transfected with miR-934 inhibitors. 160--280 neurons from four independent experiments were analyzed per condition using the Image J software and the Neuron J tool.

Statistical analysis for low throughput experiments {#s4-14}
---------------------------------------------------

All data were calculated as average of at least three independent experiments. Statistical analysis was performed using Student's t-test. All data are presented as the mean and standard error of the mean (mean ±SED). Significance is defined at \*\*\*p\<0.001, \*\*p\<0.01, \*p\<0.05.

Details of the following Methods are presented in Appendix 1: In silico analysis of miR-934 species conservation and dual luciferase assays for identification of the binding site of miR934 on the 3\'-UTR of FZD5, TFCP2L1 and RAB3B.
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Additional files {#s6}
================

###### Supplemental table 1 showing **t**he 144 miRNAs across all differentiation stages demonstrating tissue specificity index tau \>0.7.

###### Supplemental table 2 presenting The 10 most highly expressed miRNAs in NPCs demonstrating tissue specificity index tau \>0.7.

###### Supplemental table 3 showing All Blastn results with evalue \<1 for a query of the mature hsa-miR-934 sequence against all mature miRNAs in miRBase v22.1.

###### Supplemental table 4 presenting IDs and description of the small RNA-Seq human libraries of human tissue and cell data included in the analysis for miR934 expression.

###### Supplemental table 5 showing all the predicted mRNA targets for miRNA-934.

###### Supplemental table 6 presenting the 3' UTR binding sites for miR934 on its four identified targets (adapted from Diana microT-CDS).

###### Supplemental table 7 listing the **s**equences of primers and oligos used in this study.

###### Supplemental table 8 showing information on progenitor-specific and SP-enriched genes affected by sustained inhibition of miR-934.

Data availability {#s7}
=================

Sequencing data have been deposited in GEO under accession code GSE101548. All data generated or analysed during this study are included in the manuscript and supporting files.

The following datasets were generated:

ProdromidouKVlachosISGaitanouMKouroupiGHatzigeorgiouAGMatsasR2017MicroRNA-934 is a novel regulator orchestrating neurogenesis during early human neural developmentNCBI Gene Expression OmnibusGSE101548

ProdromidouKVlachosISGaitanouMKouroupiGHatzigeorgiouAGMatsasR2018MicroRNA-934 is a novel regulator orchestrating neurogenesis during early human neural developmentNCBI Gene Expression OmnibusGSE119760

The following previously published datasets were used:
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In silico analysis of miR-934 species conservation {#s8}
==================================================

To identify other species having potentially mature miRNAs with similar sequences we performed two distinct analyses: A) We searched using a sensitive blastn (The BLAST Sequence Analysis Tool, The NCBI Handbook \[Internet\]. Second Edition. Thomas Madden, Created March 15, 2013) query (e-value cutoff 1, word size 4, match score +5, mismatch penalty −4) all mature miRNAs annotated in miRBase v22.1 database ([@bib40]) against the full hsa-miR-934 mature sequence. The dataset comprises 38,859 miRNAs across 271 species. In the latest version, additional support for miRNAs is provided by the analysis of 1493 small RNA-Seq datasets. (**B**) We searched using a sensitive blastn query with similar settings as above against all miRNAs (mature, precursors) identified in MirGeneDB2.0 ([@bib25]), a new resource aiming to independently annotate miRNA genes. The dataset comprises \>10,000 miRNA genes from 45 organisms identified by the analysis of \>400 small RNA-Seq datasets. Both queries identified only primate species having a mature miRNA or miRNA precursor with similarity (e-value \<1) to the mature hsa-miR-934 sequence. miRBase database, since it is a richer resource, enabled us to identify four species (apart from human) where miR-934 is expressed ([Supplementary file 2](#supp2){ref-type="supplementary-material"}). The query against miRGeneDB 2.0 identified only hsa-miR-934 (mature and gene) as well as mml-miR-934 (mature and gene) as significant hits (e-value \<1). Only primate species (*Homo sapiens*, Pan troglodytes, Pongo pygmaeus, Macaca mulatta, Callithrix jacchus) were detected by querying all sequences deposited in the two largest datasets of mature miRNAs and miRNA precursors, providing further evidence that miR-934 is a primate specific miRNA.

![Graph incorporating miRNA expression data from uniformly-analyzed small RNA-Seq libraries of non-neural human tissue (detailed in [Supplementary file 3](#supp3){ref-type="supplementary-material"}).\
Association was noted only in one case (breast).](elife-50561-app1-fig1){#app1fig1}

![Identification of binding sites for miR-934 on the 3\'-UTR of TFCP2L1 and RAB3B.\
(**A**) Schematic representation of TFCP2L1 3'-UTR depicting in red fonts the seed-binding sequences of the two predicted MREs for miR-934 with their respective positions. To examine mechanistically the inhibition exerted by miR-934 on TFCP2L1 expression, a luciferase reporter system was used to evaluate independently the binding of miR-934 on each of the 2 MREs which contain either a 7mer, or a 9-mer site. Shown in color code are the sequences and sizes of TFCP2L1 3'-UTR regions containing the 2 MREs, as they were cloned into the pmirGLO vector \[orange: 7mer (blue box represents the last 47 base pairs at the 3' end of the human TFCP2L1 coding region); green: 9mer\]. Arrows indicate primer sites for cloning. Fragments of the 3\'-UTR of TFCP2L1 containing each of the two possible binding domains for miR-934 (218 bp, including the 7mer sequence; and 339 bp including the 9-mer sequence) were cloned separately into the 3\'-UTR of the dual luciferase reporter construct pmirGLO. (**B**) Schematic representation of RAB3B 3'-UTR depicting in red fonts the seed-binding sequences of the two predicted MREs for miR-934 with their respective positions. To examine mechanistically the inhibition exerted by miR-934 on RAB3B expression, a luciferase reporter system was used to evaluate independently the binding of miR-934 on each of the 2 MREs, which contain either a 8mer or a 7mer site. Shown in color code are the sequences and sizes of RAB3B 3'-UTR regions containing the 2 MREs, as they were cloned into the pmirGLO vector (purple: 8mer; dark blue: 7mer). Arrows indicate primer sites for cloning. Fragments of the 3\'-UTR of RAB3B containing each of the two possible binding domains for miR-934 (339 bp, including the 8mer sequence; and 342 bp including the 7-mer sequence) were cloned separately into the 3\'-UTR of the dual luciferase reporter construct pmirGLO. (**C**) Upon co-transfection of HEK293T cells with miR-934 mimics and the different TFCP2L1 and RAB3B reporter constructs, luciferase activity was suppressed in both constructs for TFCP2L1 (p=0.0002 for 7mer and p=0.0007 for 9mer) and only in the construct containing the 8mer site sequence for RAB3B (p=0.002). By contrast luciferase activity was not affected upon transfection of control constructs (pmiRGLO vector and the mutated TFCP2L1 9mer) in the presence of miR934 mimics. Color code as in (**A**) and (**B**).](elife-50561-app1-fig2){#app1fig2}

![Identification of an 8mer-seed sequence as binding site for miR-934 on the 3\'-UTR of Fzd5.\
(**A**) RT-qPCR analysis at different time points of neural induction, showing up-regulation of miR-934 and parallel down-regulation of the mRNA of its predicted target, Fzd5. Using the DIANA-microT-CDS target prediction algorithm, two putative MREs were identified on the 3\'-UTR of Fzd5. (**B**) Schematic representation of Fzd5 3'-UTR depicting in green characters the seed-binding sequences of the two predicted MREs for miR-934 with their respective positions. To examine mechanistically the inhibition exerted by miR-934 on Fzd5 expression, a luciferase reporter system was used to evaluate independently the binding of miR-934 on each of the 2 MREs which contain either a 7mer (binding score: 0.032), or an 8-mer (binding score: 0.005) site. Shown in color code are the sequences and sizes of Fzd5 3'-UTR regions containing the 2 MREs, as they were cloned into the pmirGLO vector (orange: 7mer; magenta: 8mer). Arrows indicate primer sites for cloning. Fragments of the 3\'-UTR of Fzd5 containing each of the two possible binding domains for miR-934 (1012 bp, including the 7mer sequence; and 808 bp including the 8-mer sequence) were cloned separately into the 3\'-UTR of the dual luciferase reporter construct pmirGLO. (C) Upon co-transfection of HEK293T cells with miR-934 mimics and the different Fzd5 reporter constructs, luciferase activity was only suppressed in the construct (808 bp) containing the 8mer site sequence (p=0.000008). Color code as in (**A**).](elife-50561-app1-fig3){#app1fig3}

![Heatmaps showing the expression of genes displaying no significant differences following miR-934 sustained inhibition.\
(**A**) Genes associated with intermediate progenitors, outer radial glia and cortical plate neurons. (**B**) Genes associated with regional identities during brain development.](elife-50561-app1-fig4){#app1fig4}

Dual luciferase assays for identification of the binding site of miR934 on the 3\'-UTR of Fzd5, TFCP2L1 and RAB3B {#s9}
=================================================================================================================

The full sequences of the two predicted miRNA recognition elements (MREs) of miR-934 on the 3'-UTR of Fzd5 are the following, with the seed-matched sequences underlined: MRE (7-mer): TAGAGCCAGCGATACTTTATTT**GTAGACA**; MRE (8-mer): TTTCATATGTCTTCCCAGAAAAGTAGACA. DNA fragments of the 3'-UTR of the human Frizzled class Receptor 5 (FZD5) were cloned by PCR, using human genomic DNA isolated from human fibroblasts. Primers were designed based on NM_003468.3 NCBI Reference Sequence with the knowledge that the 3'-UTR mRNA sequence of the human FZD5 derives from a single exon. The 1012 bp DNA fragment containing the 7mer sequence was produced using primers F2 and R2, and was subsequently cloned into SacI and XbaI restriction sites of the pmirGLO vector. The F3 and R1 primers were used for cloning the 808 bp DNA fragment containing the 8mer sequence. The PCR product was cloned into NheI and XbaI restrictions sites of the pmirGLO vector.

The full sequences of the two predicted miRNA recognition elements (MREs) of miR-934 on the 3'-UTR of the human transcription factor CP2-like 1 (TFCP2L1) are the following, with the seed-matched sequences underlined: MRE (7-mer): AGCCCTGTGGATCCCCGTGGAT**GTAGACA**; MRE (9-mer): AAAAAAAAAATTCTTATTTT**TAGTAGACA**. DNA fragments corresponding to the 3'-UTR of the human TFCP2L1 mRNA, were cloned by PCR, using human genomic DNA isolated from human fibroblasts. Both of the above MRE sequences are located at exon 15 of human TFCP2L1 gene. Primers were designed based on NM_014553.3 NCBI Reference Sequence. PCR products of 218 bp and 332 bp containing the 7-mer and 9-mer sequences respectively, were produced using primers F4, R4 for the 7-mer and F5, R5 for the 9-mer and were subsequently cloned separately into SacI and XbaI restriction sites of the pmirGLO vector. The seed-matched sequence corresponding to MRE (9mer) of TFCP2L1 was mutated to TA**TTCTGAT** using the Q5 Site-Directed Mutagenesis Kit (NEB) and the primers FOR mut and REV mut while DNA sequencing was performed for validation of mutated seed sites.

The full sequences of the two predicted miRNA recognition elements (MREs) of miR-934 on the 3'-UTR of the human RAB3B are the following, with the seed-matched sequences underlined: MRE (8-mer): AGGTCCTGATCCATTATATGA**AGTAGACA**; MRE (7-mer): AGTAAACTATCTTCCAACCCCT**GTAGACA**. DNA fragments corresponding to the 3'-UTR of the human RAB3B mRNA, were cloned by PCR, using human genomic DNA isolated from human fibroblasts. Both of the above MRE sequences are located at exon 5 of human RAB3B gene and primers were designed based on NM_002867.4 NCBI Reference Sequence. PCR products of 339 bp and 342 bp containing the 8-mer and 7-mer sequences respectively, were produced using primers F6, R6 for the 8-mer and F7, R7 for the 7-mer and were subsequently cloned separately into SacI and XbaI restriction sites of the pmirGLO vector.

All clones were verified by sequencing analysis. All primers used for cloning and mutagenesis are listed in [Supplementary file 7](#supp7){ref-type="supplementary-material"}. HEK293T cells were co-transfected with the modified constructs and miRNA mimics (100 nM, Exiqon/Qiagen) and luciferase activity was measured 48 hr later with the Promega Luciferase assay system.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

Prodromidou and colleagues have performed a nice study utilizing induced neural progenitor cell (NPC) to demonstrate an important role for a primate-specific mir-934 in early human neurogenesis The work is very interesting and well-presented, highlighting the evolutionary role on this microRNA which plays a role in human and non-human primates neurogenesis.

**Decision letter after peer review:**

Thank you for submitting your article \"MicroRNA-934 is a novel primate-specific small non-coding RNA with neurogenic function\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Marianne Bronner as the Senior and Reviewing Editor. The following individual involved in review of your submission has agreed to reveal their identity: Idoia Quintana-Urzainqui (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

In this work, Matsas and colleagues identify and characterize miR-934 as a primate-specific and progenitor stage specific microRNA during human pluripotent cell differentiation. Using RNA-seq, the authors detect that miR-934 is transiently expressed at the neuronal progenitor amplification state. They go on to test its role by a series of functional experiments and show that it promotes differentiation over proliferation and identify some of its potential targets.

Essential revisions:

The reviewers agree that the manuscript is potentially exciting and of interest for eventual publication in *eLife*. However, they feel that the manuscript requires further data analysis and to fully support the conclusions. For example, you need to:

1\) present a full list of miRNAs expressed at different stages and discuss how/why you have selected the mir934 and their targets from the bulk data.

2\) show the full list of targets identified after miR934 inhibition and the criteria used to select the four that are presented.

3\) provide more data to support the enrichment of subplate genes compared to other regions or compartments of the developing cortex (iSVZ, oSVZ, inner layers).

The full reviews are attached below for further details.

Reviewer \#1:

Prodromidou and colleagues presented a nice piece of work demonstrating the role of a primate-specific mir-934 which is necessary for the early human neurogenesis utilizing induced neural progenitor cell (NPC). The work is very interesting and well-presented, highlighting the evolutionary role on this microRNA having an exclusive role on human and non-human primates \'neurogenesis. However, for this reviewer there are some concerns that need to be addressed before publication.

1\) The author should present the complete list of microRNAs that are expressed at the different stages. Is miR934 the only one highly expressed at the NPCs stage?

2\) The authors used RNA-seq to identify miR-934 target, however many microRNA doesn\'t affect the expression but affect the translation. This needs to be mentioned in the Results/Discussion.

3\) It would be desired that the authors provide a complete list of miR-934 targets and their transcriptional variation after miR934 inhibition. It is not very clear if the four presented genes (STMN2, TFCP2L1, RAB3B and FZD5) are the only one presenting variation or if there are other potential targets having variations. In the same context, it is difficult to explain that having only four targets the authors observed a very broad transcriptional changes (1458 genes and 79 microRNAs). Base on this, have STMN2, TFCP2L1, RAB3B and FZD5 a very high hierarchy in the gene regulatory network that control human neurogenesis to explain the observed changes? If this is the case, it would be nice to do rescue experiment by restoring the functionality of those genes by using overexpressing constructs.

4\) The effect of miR934 inhibition on the increasing of FZD5 protein is not very obvious from the presented WB. Moreover, it is intriguing for this reviewer that the authors presented qPCR for the other three genes and WB for FZD5. On the other side it would be nice to demonstrate the effect of overexpressing the miR934 on the expression of the targets genes.

5\) The gold standard to validate the direct interaction of specific microRNAs with putative target genes is to use the entire 3\'UTRs. In this case the authors only used 29nt which wouldn\'t represent the real 3D context of the entire 3\'UTR. Moreover, they only test for one gene (they should test for the other 3 presented as a putative direct targets) and the nucleotide changes generated on the mutated form is to extreme. Generally, 2 to 3 bases on the seeds are sufficient to affect the specific binding of the microRNA without affecting the stability of the mRNA (see Ryan et al., 2016 BMC Bioinf to generate the specific mutation on the seed sequence).

Reviewer \#2:

In this manuscript, Prodromidou et al. propose that the primate specific microRNA miR-934 is a novel developmental regulator of neurogenesis. Using neural induction of stem cell cultures as a model for human brain development, they argue that miR-934 acts at the progenitor-to-neuroblast transition to regulate genes associated with progenitor cell proliferation and differentiation.

Previous work has identified many primate specific miRNAs with functions in brain development, as well as shown that some of these miRNAs have expression patterns specific to particular brain regions. Along these lines, the authors suggest that miRNA-934 specifically affects genes characteristic of the subplate, a transient brain region unique to primates. This claim is not investigated further and its relevance seems tenuous.

Overall, this manuscript provides compelling evidence that miRNA-934 is involved in regulation of genes associated with cell proliferation and neuronal differentiation during progenitor-to-neuroblast transition in primates. It could also benefit from some revisions.

1\) Figure 1A: It would be nice to see panels of all of these markers at all stages of differentiation to show how much heterogeneity/overlap of stages there is during the differentiation process.

2\) Figure 4E: The western blot shown here is not of sufficient quality to convincingly support the conclusion that FZD5 and active β-catenin are upregulated upon miR-934 inhibition. It should be cleaner (FZD5) and less saturated (β-catenin) to be able to properly quantify relative protein levels. Based on Figure 4C, \<50% of cells are experiencing miR-934 inhibition in a given sample. It would be helpful to show by immunofluorescence that GFP positive cells show an increase in FZD5 and translocation of β-catenin to the nucleus compared to non-transfected cells.

3\) Figure 5F: The authors \"compared differential RNA expression data with genes that characterize the molecular profile of prodromal/pioneer neuronal populations\" in order to \"determine the developmental stage involved,\" however they only analyze two populations-\"deep layer neurons\" for which the data is not shown, and the subplate. The data shown in this figure gives the absolute value of fold change for these genes when miR-934 is inhibited, which is strange when all the other heatmaps are based on directional fold changes. Another explanation for the change seen in \"subplate enriched genes\" is that many genes involved in many regions of the developing brain are altered downstream of perturbation during progenitor-to-neuroblast transition. To substantiate their claim the authors would need to show that genes characteristically involved in the development of several other regions of the developing brain are not dysregulated upon miR-934 inhibition. Ideally, they would also show that endogenous miR-934 is differentially expressed in the subplate compared to other brain regions. Without this validation, this data appears cherry picked and does not add anything of value to the paper.

Reviewer \#3:

In general, this is a well-executed work, with potential impact on the biology and evolution of the neocortex. My main concerns have to do with the lack of clarity in the way the results are sometimes presented, which I will detail in the following sections.

Regarding the first section of the Results, I think the characterization of the stages of differentiation of their cultured systems is convincing.

The characterization of miR-934 as a species- and stage-specific miRNA is a key point in this paper, therefore, I would like to see more detail on the analysis that led to these conclusions. The lack of clarity sometimes impedes me from assessing the real impact of the findings. Main concerns:

-- Subsection "Identification of miR-934 with species- and stage-specific expression during progenitor expansion and early neuron generation", second paragraph. The authors indicate how they identified miR934 as a high and segregated expressed miRNA, associated to the stage of neural induction. This expression is very specific and convincing, but could they give more details on how did they select this gene? Was is the only one showing this stage-specificity? How many others were included in the analysis? This will certainly help to convince the reader on how specific and, therefore, potentially important this micro RNA is for neural induction.

-- To determine the species-specificity the authors perform an in silico analysis and detect that miR-934 is only annotated in certain primates. Have the authors analysed its presence/absence in other species or animal groups? It would add value to the discovery, to include analysis in other non-primate species and even non-mammalian, showing its absence.

-- The authors show that sustained inhibition alters the expression of subplate-enriched genes and they report no difference in deep layer associated genes. Have they analysed other compartments of the developing cortex? I think they should indicate this. In particular, it would be very interesting to see whether there is any enrichment in subventricular zone/outer subventricular zone associated genes. Since they analysed deep layer genes, they could also mention if they find any change in upper layers associated genes.

\[Editors\' note: further revisions were suggested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"MicroRNA-934 is a novel primate-specific small non-coding RNA with neurogenic function during early development\" for further consideration by *eLife*. Your revised article has been reviewed by two peer reviewers and the evaluation has been overseen by Marianne Bronner as the Senior and Reviewing Editor.

While the manuscript has been improved, there are some remaining issues that need to be addressed before acceptance. I refer you to the reviewers\' comments for clarification.

Reviewer \#1:

Prodromidou and colleagues presented a new version of the manuscript demonstrating the role of a primate-specific mir-934 which is necessary for the early human neurogenesis utilizing induced neural progenitor cell (NPC). Although the authors attempt to answer most to this reviewer concerns, there are still several important points that were not addressed and are essential to support the major conclusions of the work.

In the requested list of miR-934 putative targets affected after miR934 inhibition FZD5 is not present and there are only 3 genes (STMN2, TFCP2L1, and RAB3B) (Supplementary file 5). The lack of changes in FZD5 is in agreement with the lack of a very obvious change on the WB assay (the picture is still not very convincing) and the modest change observed by qPCR (less than 1.5 fold) after miR934 inhibition. It is still not clear how the changes on these three genes may have a very broad transcriptional changes. However, based on what the author answered saying that these 3 genes have a very high hierarchy it would be very interesting that the authors make rescue experiment by adding those factor back after miR934 inhibition, but the authors never included in their new version this experiment or have discussed why this is not feasible.

Finally, the authors claim in the Discussion that they have identified four miR-934 targets (TFCP2L1, FZD5, STMN2 and RAB3B), however they partially demonstrated the direct association with Fzd5, the less affected after mir934 inhibition on the qPCR analyzes, even when this reviewer specifically requested the demonstration of this direct association for the other three factors by using luciferase assay. This experiment should be performed by using the WT and mutated 3\'UTRs (or regions of the 3\'UTRs in case those are extremely big) of the target genes.

Reviewer \#2:

In this revised manuscript, Prodromidou et al. addressed essential revisions and provided explanations for reviewer suggested revisions they did not carry out. Overall, most issues were addressed satisfactorily and the added material bolsters their conclusions, as well as increases the clarity of the paper. Issues remain, however, with Figure 4. Though the authors have added FZD5 qPCR data to support their conclusion that FZD5 is upregulated on miR-934 depletion, the western blot presented here remains problematic. The quality is insufficient to convincingly support their claim that FZD5 protein levels and activated B-catenin are increased, and this is the only data they present to support their conclusion that miR-934 inhibition of FZD5 leads to a reduction of canonical Wnt signaling. The perceived quality of the paper would benefit from a cleaner/less saturated western blot, or perhaps a reporter based assay to show that Wnt signaling is affected. I recommend this paper for acceptance once this revision is carried out.

10.7554/eLife.50561.sa2

Author response

> Essential revisions:
>
> The reviewers agree that the manuscript is potentially exciting and of interest for eventual publication in eLife. However, they feel that the manuscript requires further data analysis and to fully support the conclusions. For example, you need to:
>
> 1\) present a full list of miRNAs expressed at different stages and discuss how/why you have selected the mir934 and their targets from the bulk data.

We present new data showing how we have selected miRNA-934. In particular, we explain (Results subsection "Identification of miR-934 with species- and stage-specific expression during progenitor expansion and early neuron generation") that for this purpose, we adopted the tissue-specificity index tau, which is a reliable method for estimation of gene expression specificity and has been shown to outperform other relevant indices (Kryuchkova-Mostacci and Robinson-Rechavi, 2017). Calculation of tau index across the distinct differentiation phases revealed that 144 miRNAs exhibited a highly specific expression profile (tau\>0.7) (revised Figure 2B and Supplementary file 1A included in Supplementary file 1). For example using this computational method, miR-302 that is a known marker of pluripotency, was allocated at the hESC/iPSC stage.

Further we show that when these 144 miRNAs exhibiting tissue specificity (tau \> 0.7) were ranked by decreasing order of median expression in NPCs, miR-934 emerged on top of the list (revised Figure 2B), scoring the highest expression among other miRNAs at the NPC stage and demonstrating a strikingly segregated expression as compared to all other stages (tau value 0.76) (new Supplementary file 1). Moreover, according to median expression differences, no other miRNA was identified to have such a clear disparity against other stages.

Regarding species conservation for miR-934, we performed two distinct in silico analyses to identify species having potentially mature miRNAs with similar sequences. Both queries identified only primate species having a mature miRNA or miRNA precursor with similarity (e-value \<1) to the mature hsa-miR-934 sequence. The methodology used is now included in Appendix 1 and the results are described in the Results section (subsection "Identification of miR-934 with species- and stage-specific expression during progenitor expansion and early neuron generation") and presented in Supplementary file 2.

> 2\) show the full list of targets identified after miR934 inhibition and the criteria used to select the four that are presented.

Regarding miRNA-934 target identification, as we already explained in our original manuscript, their selection was made by exploring the RNA-seq data obtained upon transition from hESCs/iPSCs to NPCs, as well as a second set of RNA-seq data generated at the stage of neural induction of hESCs following sustained inhibition of miR-934 function via transduction with the miRZip lentivector-based anti-microRNA system. To identify miR-934 targets in each case, we integrated small RNA and RNA sequencing data using the algorithm presented in mirExTra v2. Targets were detected using microT-CDS target prediction tool as the source of potential interactions.

Using this approach we identified the four miR-934 targets presented in our original manuscript, comprising Frizzled 5 (FZD5), TFCP2L1, STMN2 (stathmin-2, SCG10) and RAB3B. Then we confirmed by qRT-PCR that sustained inhibition of miR-934 during neural induction up-regulates the 4 predicted targets FZD5, TFCP2L1, STMN2, and RAB3B. The *in silico* analysis also predicted F11R a junctional adhesion molecule and SLC16A1 a monocarboxylate transporter as potential binding partners of miR-934, yet we could not confirm changes in their mRNA expression upon miRNA-934 perturbation. This information is now included in the Results subsection "The mRNA targets of miR-934 during neural induction are associated with progenitor proliferation and neuronal differentiation" and in the revised Figure 4. No other targets, apart from the aforementioned, were predicted for miRNA-934.

> 3\) provide more data to support the enrichment of subplate genes compared to other regions or compartments of the developing cortex (iSVZ, oSVZ, inner layers).

We now present additional data highlighting the role of miR-934 in modulating molecular pathways mediating neurogenic events associated with early dorsal progenitor populations and the subplate zone (Results subsection "Inhibition of miR-934 during neural induction affects molecular pathways of neurogenesis and alters the expression of subplate-enriched genes").

In this regard, we attest that apart from the genes reported in our original manuscript regarding cellular identities and the subplate region (Figure 5F and validation by qRT-PCR in Figure 5G; Supplementary file 7), we did not observe any differences in the expression of the transcription factor Tbr2 (EOMES) that characterizes intermediate progenitors or the outer radial glia marker HOPX (now shown in new Appendix 1---figure 3A). Moreover, we indicate that there were no changes in ventral or mid-brain fate specification markers, including DLX1, DLX2, ALSC1, PAX2 and GBX2 which all exhibited lower expression as compared to the dorsal forebrain marker EMX2 (new Appendix 1---figure 3B). Of interest, we did not detect expression of early markers of lateral and medial ganglionic eminences, such as Nkx2.1, GSX1 and GSX2 with or without miR-934 perturbation.

Further to determine the developmental stage involved, we compared differential RNA expression data for genes that characterize the molecular profile of prodromal/pioneer neuronal populations during cortical development. We detected low expression in a series of early neuronal markers, while further analysis did not reveal miR-934-mediated differences in the expression of genes characterizing deep layer neurons, such as FEZF2, TBR1, FOXP2 and CTIP2 (BCL11B), or the early fate determinant of upper layer neurons CUX2 (51) (Appendix 1---figure 3A). We detected expression of SATB2, which is reported to be co-expressed with CTIP2 in a subset of early neurons of the visual cortex, yet this transcription factor presented no change upon miR-934 perturbation (Appendix 1---figure 3A).

This data further support the role of miR-934 in modulating molecular pathways mediating neurogenic events associated with early dorsal progenitor populations and the subplate zone.

> The full reviews are attached below for further details.
>
> Reviewer \#1:
>
> Prodromidou and colleagues presented a nice piece of work demonstrating the role of a primate-specific mir-934 which is necessary for the early human neurogenesis utilizing induced neural progenitor cell (NPC). The work is very interesting and well-presented, highlighting the evolutionary role on this microRNA having an exclusive role on human and non-human primates \'neurogenesis. However, for this reviewer there are some concerns that need to be addressed before publication.
>
> 1\) The author should present the complete list of microRNAs that are expressed at the different stages. Is miR934 the only one highly expressed at the NPCs stage?

We have addressed this comment, please see essential revisions above.

> 2\) The authors used RNA-seq to identify miR-934 target, however many microRNA doesn\'t affect the expression but affect the translation. This needs to be mentioned in the Results/Discussion.

We have added a relevant comment in the second paragraph of the Discussion.

> 3\) It would be desired that the authors provide a complete list of miR-934 targets and their transcriptional variation after miR934 inhibition. It is not very clear if the four presented genes (STMN2, TFCP2L1, RAB3B and FZD5) are the only one presenting variation or if there are other potential targets having variations. In the same context, it is difficult to explain that having only four targets the authors observed a very broad transcriptional changes (1458 genes and 79 microRNAs). Base on this, have STMN2, TFCP2L1, RAB3B and FZD5 a very high hierarchy in the gene regulatory network that control human neurogenesis to explain the observed changes? If this is the case, it would be nice to do rescue experiment by restoring the functionality of those genes by using overexpressing constructs.

We have addressed the comment regarding the full list of target identification, please see essential revisions above.

Regarding the reviewer's comment on the brad transcriptional changes observed upon miRNA-934 sustained inhibition, we have added a comment in the second paragraph of the Discussion arguing that the identified targets play a role in diverse processes along the neurogenic program including stem cell self-renewal, neural progenitor proliferation and differentiation as well as cytoskeletal arrangement and neurotransmission. It is therefore conceivable that miR-934-mediated modulation in the expression of these molecules should further influence downstream pathways related to morphological and functional transition of neural progenitor cells, thus causing an amplification in gene expression changes. Consistently, we observed altered expression in a total of 1458 genes upon miR-934 inhibition.

We also argue that the downstream implications of miR-934 on post-transcriptional control of gene expression may be even broader since miRNAs, besides causing mRNA degradation, may also act to inhibit translation of their mRNA targets thus affecting expression at the protein level.

> 4\) The effect of miR934 inhibition on the increasing of FZD5 protein is not very obvious from the presented WB. Moreover, it is intriguing for this reviewer that the authors presented qPCR for the other three genes and WB for FZD5. On the other side it would be nice to demonstrate the effect of overexpressing the miR934 on the expression of the targets genes.

We now present qRT-PCR results for FZD5.

We feel that sustained inhibition of miRNA-934 is more sensitive for assessing the effects on target genes, since often overexpression may not have the expected influence, particularly if levels are already saturated.

> 5\) The gold standard to validate the direct interaction of specific microRNAs with putative target genes is to use the entire 3\'UTRs. In this case the authors only used 29nt which wouldn\'t represent the real 3D context of the entire 3\'UTR. Moreover, they only test for one gene (they should test for the other 3 presented as a putative direct targets) and the nucleotide changes generated on the mutated form is to extreme. Generally, 2 to 3 bases on the seeds are sufficient to affect the specific binding of the microRNA without affecting the stability of the mRNA (see Ryan et al., 2016 BMC Bioinf to generate the specific mutation on the seed sequence).

We have tested binding particularly for Fzd5 in order to assess whether binding of miR-934 involves a conserved site on the 3'UTR of Fzd5. In this case, we performed experiments by cloning the respective 29 nt and also by cloning fragment of the entire 3'UTR containing the respective site. Since the 3'UTR of Fzd5, which is a particularly large 3'UTR, contains 2 candidate sites for interaction with miR-934, we used separate fragments of the 3'UTR for cloning in order to distinguish the 2 binding sites and identify the true region of interaction with miR-934.

> Reviewer \#2:
>
> \[...\] Overall, this manuscript provides compelling evidence that miRNA-934 is involved in regulation of genes associated with cell proliferation and neuronal differentiation during progenitor-to-neuroblast transition in primates. It could also benefit from some revisions.
>
> 1\) Figure 1A: It would be nice to see panels of all of these markers at all stages of differentiation to show how much heterogeneity/overlap of stages there is during the differentiation process.

We appreciate the comment of this reviewer. However, we feel that our global transcriptomic data show clearly that cells sequester primarily according to differentiation stage, a fact that we also observe by immunocytochemistry for cell-type-specific markers.

> 2\) Figure 4E: The western blot shown here is not of sufficient quality to convincingly support the conclusion that FZD5 and active β-catenin are upregulated upon miR-934 inhibition. It should be cleaner (FZD5) and less saturated (β-catenin) to be able to properly quantify relative protein levels. Based on Figure 4C, \<50% of cells are experiencing miR-934 inhibition in a given sample. It would be helpful to show by immunofluorescence that GFP positive cells show an increase in FZD5 and translocation of β-catenin to the nucleus compared to non-transfected cells.

We now also present qRT-PCR results for FZD5 confirming its up-regulation upon miR-934 inhibition.

Unfortunately we could not perform the experiment suggested by this reviewer for β-catenin translocation because our available antibody does not give a clear picture by immunofluorescence.

> 3\) Figure 5F: The authors \"compared differential RNA expression data with genes that characterize the molecular profile of prodromal/pioneer neuronal populations\" in order to \"determine the developmental stage involved,\" however they only analyze two populations-\"deep layer neurons\" for which the data is not shown, and the subplate. The data shown in this figure gives the absolute value of fold change for these genes when miR-934 is inhibited, which is strange when all the other heatmaps are based on directional fold changes. Another explanation for the change seen in \"subplate enriched genes\" is that many genes involved in many regions of the developing brain are altered downstream of perturbation during progenitor-to-neuroblast transition. To substantiate their claim the authors would need to show that genes characteristically involved in the development of several other regions of the developing brain are not dysregulated upon miR-934 inhibition. Ideally, they would also show that endogenous miR-934 is differentially expressed in the subplate compared to other brain regions. Without this validation, this data appears cherry picked and does not add anything of value to the paper.

We have addressed this comment, please see essential revisions above.

> Reviewer \#3:
>
> In general, this is a well-executed work, with potential impact on the biology and evolution of the neocortex. My main concerns have to do with the lack of clarity in the way the results are sometimes presented, which I will detail in the following sections.
>
> Regarding the first section of the Results, I think the characterization of the stages of differentiation of their cultured systems is convincing.
>
> The characterization of miR-934 as a species- and stage-specific miRNA is a key point in this paper, therefore, I would like to see more detail on the analysis that led to these conclusions. The lack of clarity sometimes impedes me from assessing the real impact of the findings. Main concerns:
>
> -- Subsection "Identification of miR-934 with species- and stage-specific expression during progenitor expansion and early neuron generation", second paragraph. The authors indicate how they identified miR934 as a high and segregated expressed miRNA, associated to the stage of neural induction. This expression is very specific and convincing, but could they give more details on how did they select this gene? Was is the only one showing this stage-specificity? How many others were included in the analysis? This will certainly help to convince the reader on how specific and, therefore, potentially important this micro RNA is for neural induction.

We have addressed this comment, please see essential revisions above.

> -- To determine the species-specificity the authors perform an in silico analysis and detect that miR-934 is only annotated in certain primates. Have the authors analysed its presence/absence in other species or animal groups? It would add value to the discovery, to include analysis in other non-primate species and even non-mammalian, showing its absence.

We have addressed this comment, please see essential revisions above.

> -- The authors show that sustained inhibition alters the expression of subplate-enriched genes and they report no difference in deep layer associated genes. Have they analysed other compartments of the developing cortex? I think they should indicate this. In particular, it would be very interesting to see whether there is any enrichment in subventricular zone/outer subventricular zone associated genes. Since they analysed deep layer genes, they could also mention if they find any change in upper layers associated genes.

We have addressed this comment, please see essential revisions above.

\[Editors\' note: further revisions were suggested prior to acceptance, as described below.\]

> While the manuscript has been improved, there are some remaining issues that need to be addressed before acceptance. I refer you to the reviewers\' comments for clarification.
>
> Reviewer \#1:
>
> Prodromidou and colleagues presented a new version of the manuscript demonstrating the role of a primate-specific mir-934 which is necessary for the early human neurogenesis utilizing induced neural progenitor cell (NPC). Although the authors attempt to answer most to this reviewer concerns, there are still several important points that were not addressed and are essential to support the major conclusions of the work.
>
> In the requested list of miR-934 putative targets affected after miR934 inhibition FZD5 is not present and there are only 3 genes (STMN2, TFCP2L1, and RAB3B) (Supplementary file 5). The lack of changes in FZD5 is in agreement with the lack of a very obvious change on the WB assay (the picture is still not very convincing) and the modest change observed by qPCR (less than 1.5 fold) after miR934 inhibition. It is still not clear how the changes on these three genes may have a very broad transcriptional changes. However, based on what the author answered saying that these 3 genes have a very high hierarchy it would be very interesting that the authors make rescue experiment by adding those factor back after miR934 inhibition, but the authors never included in their new version this experiment or have discussed why this is not feasible.

We have now improved the quality of the immunoblot in Figure 4 relating to FZD5 protein levels, clearly showing that Fzd5 protein is upregulated upon miR934 inhibition.

Regarding the rescue experiments and following correspondence with the Editor, it has been agreed that these are very challenging both in technical terms and also in faithfully simulating the pleiotropic spatiotemporal control of miRNAs, exceeding the scope of the present manuscript.

> Finally, the authors claim in the Discussion that they have identified four miR-934 targets (TFCP2L1, FZD5, STMN2 and RAB3B), however they partially demonstrated the direct association with Fzd5, the less affected after mir934 inhibition on the qPCR analyzes, even when this reviewer specifically requested the demonstration of this direct association for the other three factors by using luciferase assay. This experiment should be performed by using the WT and mutated 3\'UTRs (or regions of the 3\'UTRs in case those are extremely big) of the target genes.

We have generated 4 modified constructs of the dual luciferase reporter pmirGLO vector following cloning of 2 fragments of the 3\'-UTR of TFCP2L1 containing each of the two possible binding domains for miR-934 (218 bp, including the 7mer sequence; and 339 bp including the 9-mer sequence) and cloning of another 2 fragments of the 3\'-UTR of RAB3B containing each of the two possible binding domains for miR-934 (339 bp, including the 8mer sequence; and 342 bp including the 7-mer sequence). A mutated version of the seed-matched sequence corresponding to 9mer containing MRE of TFCP2L1 was also generated and the respective construct was cloned into the pmiRGLO vector serving as a control for the luciferase assay (Appendix 1 for methodology). Co-transfection of HEK293T cells with miR-934 mimics and the different TFCP2L1 and RAB3B reporter constructs suppressed luciferase activity in both constructs for TFCP2L1 (p=0.0002 for 7mer and p=0.0007 for 9mer) and only in the construct containing the 8mer site sequence for RAB3B (p=0.002). By contrast luciferase activity was not affected upon transfection of control constructs (pmiRGLO vector and the mutated TFCP2L1 9mer) in the presence of miR934 mimics. These data confirm TFCP2L1 and RAB3B as binding partners of miR934 and validate specific predicted sites as regions of interaction. (subsection "The mRNA targets of miR-934 during neural induction are associated with progenitor proliferation and neuronal differentiation", new Appendix 1---figure 2 and Appendix 1 for figure legend).

Unfortunately due to the lockdown, we were unable to produce additional constructs required for validation of STMN2 as a direct miR934 target and the remaining mutated constructs, but we hope that the reviewer will find this acceptable given the circumstances, also considering that all performed validation assays confirmed bioinformatics data for target prediction, as well as taking into account the complete set of data presented in our article.

> Reviewer \#2:
>
> In this revised manuscript, Prodromidou et al. addressed essential revisions and provided explanations for reviewer suggested revisions they did not carry out. Overall, most issues were addressed satisfactorily and the added material bolsters their conclusions, as well as increases the clarity of the paper. Issues remain, however, with Figure 4. Though the authors have added FZD5 qPCR data to support their conclusion that FZD5 is upregulated on miR-934 depletion, the western blot presented here remains problematic. The quality is insufficient to convincingly support their claim that FZD5 protein levels and activated B-catenin are increased, and this is the only data they present to support their conclusion that miR-934 inhibition of FZD5 leads to a reduction of canonical Wnt signaling. The perceived quality of the paper would benefit from a cleaner/less saturated western blot, or perhaps a reporter based assay to show that Wnt signaling is affected. I recommend this paper for acceptance once this revision is carried out.

As stated above we have now improved the quality of the immunoblot in Figure 4 relating to FZD5 and β-catenin protein levels, clearly showing that Wnt signaling is affected.

[^1]: These authors contributed equally to this work.
